Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10

Further Publications Dermatology

Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study

JAMA Dermatol

Kridin K, Brüggen MC, Chua SL, Bygum A, Walsh S, Nägeli MC, Kucinskiene V, French L, Tétart F, Didona B, Milpied B, Ranki A, Salavastru C, Brezinová E, Divani-Patel S, Lorentzen T, Nagel JL, Valiukeviciene S, Karpaviciute V, Tiplica GS, Oppel E, Oschmann A, de Prost N, Vorobyev A, Ingen-Housz-Oro S

doi: 10.1001/jamadermatol.2021.3154

Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis

JAMA Dermatol.

Zimmermann S, Sekula P, Venhoff M, Motschall E, Knaus J, Schumacher M, Mockenhaupt M

doi: 10.1001/

Further Publications Dermatology

Survival after Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis: A UK-based Cohort Study

J Invest Dermatol

Marxer CA, Frey N, Bodmer M, Bircher A, Jick SS, Meier CR, Spoendlin J

doi: 10.1016/j.jid.2020.09.034

Further Publications Rheumatology

Risk of serious infections in arthritis patients treated with biological drugs: a matched cohort study and development of prediction model

Rheumatology (Oxford)

Krabbe S, Grøn KL, Glintborg B, Nørgaard M, Mehnert F, Jarbøl DE, Østergaard M, Hetland ML

doi: 10.1093/rheumatology/keaa876

Further Publications Rheumatology

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis

JAMA

WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group., Shankar-Hari M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, Savovic J, Tierney J, Baron G, Benbenishty JS, Berry LR, Broman N, Cavalcanti AB, Colman R, De Buyser SL, Derde LPG, Domingo P, Omar SF, Fernandez-Cruz A, Feuth T, Garcia F, Garcia-Vicuna R, Gonzalez-Alvaro I, Gordon AC, Haynes R, Hermine O, Horby PW, Horick NK, Kumar K, Lambrecht BN, Landray MJ, Leal L, Lederer DJ, Lorenzi E, Mariette X, Merchante N, Misnan NA, Mohan SV, Nivens MC, Oksi J, Perez-Molina JA, Pizov R, Porcher R, Postma S, Rajasuriar R, Ramanan AV, Ravaud P, Reid PD, Rutgers A, Sancho-Lopez A, Seto TB, Sivapalasingam S, Soin AS, Staplin N, Stone JH, Strohbehn GW, Sunden-Cullberg J, Torre-Cisneros J, Tsai LW, van Hoogstraten H, van Meerten T, Veiga VC, Westerweel PE, Murthy S, Diaz JV, Marshall JC, Sterne JAC

doi: 10.1001/jama.2021.11330

Methotrexate-induced epidermal necrosis: A case series of 24 patients

J Am Acad Dermatol.

Chen TJ, Chung WH, Chen CB, Hui RC, Huang YH, Lu YT, Wang CW, Wang KH, Yang LC, Hung SI

doi: 10.1016/j.jaad.2017.02.021.

Melanoma and Skin Cancer

Assessment of Deep Learning Using Nonimaging Information and Sequential Medical Records to Develop a Prediction Model for Nonmelanoma Skin Cancer

JAMA Dermatol.

Wang HH, Wang YH, Liang CW, Li YC

doi: 10.1001/jamadermatol.2019.2335.

RECOMMENDED

Systemic Sclerosis

Exercise Echocardiography Predicts Future Development of Pulmonary Hypertension in a High-Risk Cohort of Scleroderma Patients

★ 1 Recommended by Dr Heino Prillwitz, Faculty Member

J Rheumatol.

Quinn KA, Wappel SR, Kuru T, Steen VD

doi: 10.3899/jrheum.190226.